Roivant Sciences Ltd. SEC filings ROIV
Roivant Sciences Ltd. has 995 filings in SEC EDGAR's recent list, going back to Mar 16, 2015. Its latest annual report, Form ARS, was filed on Jul 29, 2026 for the period ended Mar 31, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (regulation fd disclosure). The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | May 20, 2026 | — |
| S-3ASR | Automatic shelf registration | Oct 3, 2025 | — |
| S-8 | Employee stock plan registration | Jul 26, 2024 | — |
| 424B5 | Prospectus supplement | Oct 6, 2023 | — |
| S-3 | Shelf registration | Sep 29, 2023 | — |
| 424B5 | Prospectus supplement | Sep 26, 2023 | — |
| S-8 | Employee stock plan registration | Jun 29, 2023 | — |
| 424B5 | Prospectus supplement | Feb 6, 2023 | — |
| 424B5 | Prospectus supplement | Feb 1, 2023 | — |
| 424B5 | Prospectus supplement | Nov 9, 2022 | — |
| 424B5 | Prospectus supplement | Nov 8, 2022 | — |
| 424B7 | Filing | Oct 3, 2022 | — |
| 424B5 | Prospectus supplement | Oct 3, 2022 | — |
| 424B5 | Prospectus supplement | Oct 3, 2022 | — |
| POS AM | Filing | Sep 29, 2022 | — |
| POS AM | Filing | Sep 29, 2022 | — |
| POS AM | Filing | Sep 29, 2022 | — |
| S-3 | Shelf registration | Sep 19, 2022 | — |
| 424B3 | Prospectus | Aug 15, 2022 | — |
| 424B3 | Prospectus | Aug 15, 2022 | — |
| 424B3 | Prospectus | Aug 15, 2022 | — |
| POS AM | Filing | Jul 29, 2022 | — |
| S-8 | Employee stock plan registration | Jun 28, 2022 | — |
| 424B3 | Prospectus | Jun 28, 2022 | — |
| 424B3 | Prospectus | Jun 28, 2022 | — |
| 424B3 | Prospectus | Jun 28, 2022 | — |
| 424B3 | Prospectus | May 24, 2022 | — |
| 424B3 | Prospectus | May 24, 2022 | — |
| 424B3 | Prospectus | May 24, 2022 | — |
| 424B3 | Prospectus | Apr 1, 2022 | — |
| S-1/A | Amended registration statement | Mar 31, 2022 | — |
| 424B3 | Prospectus | Mar 30, 2022 | — |
| 424B3 | Prospectus | Mar 30, 2022 | — |
| 424B3 | Prospectus | Feb 28, 2022 | — |
| 424B3 | Prospectus | Feb 28, 2022 | — |
| S-1 | Registration statement | Feb 17, 2022 | — |
| 424B3 | Prospectus | Feb 14, 2022 | — |
| 424B3 | Prospectus | Feb 14, 2022 | — |
| 424B3 | Prospectus | Jan 4, 2022 | — |
| S-1 | Registration statement | Dec 22, 2021 | — |
| 424B3 | Prospectus | Nov 15, 2021 | — |
| 424B3 | Prospectus | Nov 9, 2021 | — |
| S-1 | Registration statement | Oct 29, 2021 | — |
| S-8 | Employee stock plan registration | Oct 8, 2021 | — |
| 424B3 | Prospectus | Aug 10, 2021 | — |
| S-4/A | Filing | Aug 9, 2021 | — |
| S-4/A | Filing | Aug 3, 2021 | — |
| S-4/A | Filing | Jul 22, 2021 | — |
| S-4/A | Filing | Jul 1, 2021 | — |
| S-4 | Registration for a merger or exchange | May 14, 2021 | — |
Showing 50 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ROIV (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- Bermuda
- Headquarters
- London
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1635088
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.